Alchemi
1 known investors
Find your way into Alchemi
Sign up to see every warm intro you have to Alchemi
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alchemi team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Alchemi combines AI with scientific expertise to accelerate drug development timelines and reduce time-to-market for therapies. The company serves pharmaceutical development teams and aims to lower drug costs and improve access to medicines.
Founders & leadership
Board
MD
Mikael Dolsten
Investors · 1
Maple VClisted by Maple VCSan Francisco · $500K – $1.5M
How we know: Maple VC's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Alchemi do?
- Alchemi combines AI with scientific expertise to accelerate drug development timelines and reduce time-to-market for therapies. The company serves pharmaceutical development teams and aims to lower drug costs and improve access to medicines.
- Who founded Alchemi?
- Alchemi was founded by Tom Mulvey, Anuj Chadha, Caroline Atyeo.
- Who are Alchemi's investors?
- Alchemi's investors include Maple VC.




